Literature DB >> 8364975

Expression of vigilin in chicken cartilage and bone.

G Plenz1, Y Gan, H M Raabe, P K Müller.   

Abstract

The expression of vigilin was followed during chick embryonal development by in situ hybridization. Vigilin mRNA is abundantly expressed in tissues of mesenchymal and ectomesenchymal origin. The mesenchymal primordial cells of cartilage and bone did not show any significant expression of vigilin. As tissue differentiation proceeded, vigilin mRNA levels increased in hyaline cartilage and in both endochondral as well as intramembranous bone. The results suggest that the expression of vigilin mRNA in cartilage- and bone-forming cells, chondrocytes and osteoblasts, is dependent on the stage of development and cellular differentiation, although not a unique process of bone formation. Most striking is the correlation of the maximum vigilin mRNA expression in osteoblasts and hypertrophic chondrocytes to periods when cell-specific genes were highly transcribed and substantially translated, e.g., synthesis of procollagen and formation of extracellular matrix in bone and cartilage.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8364975     DOI: 10.1007/bf00312841

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  19 in total

1.  Calcium deficiency induces expression of cartilage-like phenotype in chick embryonic calvaria.

Authors:  O Jacenko; R S Tuan
Journal:  Dev Biol       Date:  1986-05       Impact factor: 3.582

2.  A series of normal stages in the development of the chick embryo.

Authors:  V HAMBURGER; H L HAMILTON
Journal:  J Morphol       Date:  1951-01       Impact factor: 1.804

3.  Expression of collagen type transcripts in chick embryonic bone detected by in situ cDNA-mRNA hybridization.

Authors:  S A McDonald; R S Tuan
Journal:  Dev Biol       Date:  1989-05       Impact factor: 3.582

4.  Levels of collagen mRNA in dedifferentiating chondrocytes.

Authors:  M Duchêne; M E Sobel; P K Müller
Journal:  Exp Cell Res       Date:  1982-12       Impact factor: 3.905

5.  Analysis of cDNA and genomic clones coding for the pro alpha 1 chain of calf type II collagen.

Authors:  F O Sangiorgi; V Benson-Chanda; W J de Wet; M E Sobel; F Ramirez
Journal:  Nucleic Acids Res       Date:  1985-04-25       Impact factor: 16.971

6.  Complete cDNA sequence of chicken vigilin, a novel protein with amplified and evolutionary conserved domains.

Authors:  C Schmidt; B Henkel; E Pöschl; H Zorbas; W G Purschke; T R Gloe; P K Müller
Journal:  Eur J Biochem       Date:  1992-06-15

7.  Chicken vigilin gene organization and expression pattern. The domain structure of the protein is reflected by the exon structure.

Authors:  B Henkel; C Schmidt; H Zorbas; E Pöschl; T R Gloe; W G Purschke; P K Müller
Journal:  Eur J Biochem       Date:  1992-10-01

8.  Cloning a cDNA for the pro-alpha 2 chain of human type I collagen.

Authors:  J C Myers; M L Chu; S H Faro; W J Clark; D J Prockop; F Ramirez
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

9.  Immunohistochemical localization of short chain cartilage collagen (type X) in avian tissues.

Authors:  T M Schmid; T F Linsenmayer
Journal:  J Cell Biol       Date:  1985-02       Impact factor: 10.539

10.  Gene regulation during cartilage differentiation: temporal and spatial expression of link protein and cartilage matrix protein in the developing limb.

Authors:  N S Stirpe; P F Goetinck
Journal:  Development       Date:  1989-09       Impact factor: 6.868

View more
  8 in total

1.  Proteomic analysis of mineralising osteoblasts identifies novel genes related to bone matrix mineralisation.

Authors:  Fawzy A Saad; Jochen G Hofstaetter
Journal:  Int Orthop       Date:  2010-06-18       Impact factor: 3.075

2.  In vitro genetic analysis of the RNA binding site of vigilin, a multi-KH-domain protein.

Authors:  H Kanamori; R E Dodson; D J Shapiro
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

3.  Chicken vigilin gene: a distinctive pattern of hypersensitive sites is characteristic for its transcriptional activity.

Authors:  A Grünweller; W G Purschke; S Kügler; C Kruse; P K Müller
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

4.  Experimental tissue expansion induces changes in expression of procollagen I and III messenger RNA.

Authors:  J A Löffler; G Plenz; R Siegert; H Weerda; P K Müller
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

5.  tRNA is entrapped in similar, but distinct, nuclear and cytoplasmic ribonucleoprotein complexes, both of which contain vigilin and elongation factor 1 alpha.

Authors:  C Kruse; A Grünweller; D K Willkomm; T Pfeiffer; R K Hartmann; P K Müller
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

6.  Evidence for a novel cytoplasmic tRNA-protein complex containing the KH-multidomain protein vigilin.

Authors:  C Kruse; A Grünweller; H Notbohm; S Kügler; W G Purschke; P K Müller
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

7.  The human vigilin gene: identification, chromosomal localization and expression pattern.

Authors:  G Plenz; S Kügler; S Schnittger; H Rieder; C Fonatsch; P K Müller
Journal:  Hum Genet       Date:  1994-05       Impact factor: 4.132

8.  RNAi-mediated depletion of the 15 KH domain protein, vigilin, induces death of dividing and non-dividing human cells but does not initially inhibit protein synthesis.

Authors:  Kathryn M Goolsby; David J Shapiro
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.